Fields marked with an asterisk (*) are required.
Name *
Username *
Password *
Verify password *
Email *
Verify email *
Search Search

 

CHAPTER 400 - PATENTS ACT: SUBSIDIARY LEGISLATION

 

INDEX TO SUBSIDIARY LEGISLATION

Patents (Manufacture of Patented Antiretroviral Drugs) (Authorisation) Regulations, 2004

Patents (Convention Countries) Notice

Patent Office (Establishment) Order

Patents Regulations

Patents (Appeals) Rules

Patents Act (Commencement) Order

 

PATENTS (MANUFACTURE OF PATENTED ANTIRETROVIRAL DRUGS) (AUTHORISATION) REGULATIONS, 2004

[Section 40]

Arrangement of Regulations

   Regulation

   1. Title

   2. Interpretation

   3. Authority to manufacture antiretroviral drugs

   4. Antiretroviral drugs to be exported

SI 83 of 2004.

1. Title

These Regulations may be cited as the Patents (Manufacture of Patented Antiretroviral Drugs) (Authorisation) Regulations, 2004.

2. Interpretation

In these Regulations unless the context otherwise requires–

“antiretroviral drug” includes any generic drug used in the treatment of persons suffering from HIV/AIDS or an HIV/AIDS related condition;

“patented antiretroviral drug” means any antiretroviral drug in respect of which a patent has been granted and is for the time being in force; and

“period of emergency” means the period commencing on 1stAugust, 2004 and ending on 31stJuly, 2009.

3. Authority to manufacture antiretroviral drugs

The Minister may, in writing, authorise any Government department or person to manufacture, use or vend, in Zambia, any patented antiretroviral drug during the period of emergency.

4. Antiretroviral drugs to be exported

Antiretroviral drugs that are manufactured pursuant to Regulation 3 shall not be exported to any place outside Zambia.

 


This section of the article is only available for our subscribers. Please click here to subscribe to a subscription plan to view this part of the article.